Investing Insights: Dividends, Mid-Caps, Social Security
On this week's podcast, our take on Guidewire, a suite of foreign-stock index funds from Fidelity, and what curbing rebates could mean for drug manufacturers.
On this week's podcast, our take on Guidewire, a suite of foreign-stock index funds from Fidelity, and what curbing rebates could mean for drug manufacturers.
Editor's note: We are presenting Morningstar's Investing Insights podcast here. You can subscribe for free on iTunes.
***
Morningstar.com does not own shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.